secwatch.observer — SEC 8-K summary
======================================

Issuer:     Caribou Biosciences, Inc. (CRBU)
CIK:        0001619856
Form:       8-K
Filed at:   2021-07-28T23:59:59+00:00
Accession:  0001193125-21-227378
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 3.02, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Caribou Biosciences completes $304M IPO; sells 19M shares at $16 each
---------------------------------------------------------------------

- Gross proceeds of $304M before underwriting discounts; underwriters have 30-day option for up to 2.85M additional shares.
- All outstanding preferred stock (Series A, A-1, B, C) converted into 26,234,654 common shares automatically prior to IPO close.
- Director Jeffrey Long-McGie resigned effective July 27, 2021, in connection with the IPO closing; no disagreement cited.
- Adopted 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan; entered amended employment agreements with four named officers.
- Filed amended and restated certificate of incorporation and bylaws effective July 27, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1619856/000119312521227378/0001193125-21-227378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1619856/000119312521227378/d189230d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-227378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer